Agilysys Q1 2026 Earnings EPS Surpasses Expectations by 244 Amid Concerns Over Revenue Disclosure PRAX Q1 2026 Earnings Narrowerthanexpected loss as Praxis Precision Medicines advances pipeline OSRH Q4 2025 Earnings EPS Miss of 569 Triggers Stock Decline EXPE Q1 2026 Earnings Strong EPS Beat Amid Revenue Uncertainty CLYM Q1 2026 Earnings NarrowerThanExpected Loss Supports Positive Investor Sentiment Dyne Therapeutics Q1 2026 Earnings Narrower Loss Beats Estimates as Pipeline Advances